{"entity":{"id":"nct06731894","kind":"trial","name":"Phytocannabinoids for Reducing Chronic Chemotherapy-Induced Peripheral Neuropathy in Breast and Colon Cancer Survivors","aka":[],"tldr":"A phase 2 trial of Dronabinol in Breast cancer, run by City of Hope Medical Center, now recruiting.","summary":"Phytocannabinoids for Reducing Chronic Chemotherapy-Induced Peripheral Neuropathy in Breast and Colon Cancer Survivors is a phase 2 interventional study registered as NCT06731894 by City of Hope Medical Center, with 120 participants planned, started 2025-10-03 and due to reach its primary completion in 2028-01-07. Interventions recorded: Biospecimen Collection, Cannabidiol, Dronabinol, Placebo Administration, Survey Administration. Conditions recorded: Breast Carcinoma, Chemotherapy-Induced Peripheral Neuropathy, Colon Carcinoma.\n\nLinked to the drug Dronabinol because the registry names it among its interventions and Breast cancer among its conditions. Registry record only: no result has been read by an editor.","status":"recruiting","asOf":"2026-09-22","links":[{"label":"ClinicalTrials.gov NCT06731894","url":"https://clinicaltrials.gov/study/NCT06731894"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["breast-cancer"],"sections":[],"technologies":[],"targets":[],"drugs":["dronabinol"],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT06731894","phase":"2","setting":"A Pilot Study to Evaluate the Benefits of Phytocannabinoids for the Treatment of Chronic Chemotherapy-Induced Peripheral Neuropathy","sponsor":"City of Hope Medical Center","enrolled":120,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct06731894/","neighbours":{"cancer":[{"id":"breast-cancer","kind":"cancer","name":"Breast cancer (all types)","route":"/cancers/breast-cancer/"}],"drug":[{"id":"dronabinol","kind":"drug","name":"Dronabinol","route":"/drugs/dronabinol/"}]}}